We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.86B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.14B
AUM Growth
+$140M
Cap. Flow
+$83.4M
Cap. Flow %
3.9%
Top 10 Hldgs %
40.56%
Holding
223
New
11
Increased
84
Reduced
50
Closed
12
Avg Time Held
10.1 quarters
Top 10 Avg Time Held
7.6 quarters
Top 20 Avg Time Held
8.2 quarters

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$21.5M
2
MRK icon
Merck
MRK
+$15.8M
3
WY icon
Weyerhaeuser
WY
+$15M
4
AVGO icon
Broadcom
AVGO
+$12.9M
5
FDX icon
FedEx
FDX
+$6.19M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20M
2
ABB
ABB Ltd
ABB
+$13.9M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.73M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$2.81M
5
APC icon
Anadarko Petroleum
APC
+$1.9M

Sector Composition

Rank Sector Weight
1 Industrials 19.18%
2 Communication Services 17.11%
3 Healthcare 16.21%
4 Financials 14.28%
5 Consumer Staples 12.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
UPS icon
51
United Parcel Service
UPS
$81.1B
$12.9M 0.6%
119,615
+6,731
+6% +$701K
2013 Q2
12 quarters
KSU
52
DELISTED
Kansas City Southern
KSU
$12.8M 0.6%
142,600
– –
2013 Q2
12 quarters
PFE icon
53
Pfizer
PFE
$162B
$12.3M 0.57%
366,773
+6,470
+2% +$206K
2013 Q2
12 quarters
VOD icon
54
Vodafone
VOD
$35.7B
$11.4M 0.53%
369,993
+12,684
+4% +$412K
2014 Q2
8 quarters
TEVA icon
55
Teva Pharmaceutical Industries Limited
TEVA
$48B
$9.69M 0.45%
192,847
+38,322
+25% +$2.04M
2013 Q2
12 quarters
COP icon
56
ConocoPhillips
COP
$165B
$9.42M 0.44%
215,987
+3,570
+2% +$157K
2013 Q2
12 quarters
CVX icon
57
Chevron
CVX
$422B
$9.36M 0.44%
89,243
+1,903
+2% +$191K
2013 Q2
12 quarters
CB icon
58
Chubb
CB
$133B
$9.27M 0.43%
70,944
+1,428
+2% +$176K
2013 Q2
12 quarters
GL icon
59
Globe Life
GL
$12.7B
$8.9M 0.42%
144,013
– –
2013 Q2
12 quarters
JPM icon
60
JPMorgan Chase
JPM
$889B
$7.91M 0.37%
127,337
-2,651
-2% -$166K
2013 Q2
12 quarters
PM icon
61
Philip Morris
PM
$315B
$7.6M 0.36%
74,752
-200
-0.3% -$19.9K
2013 Q2
12 quarters
NSC icon
62
Norfolk Southern
NSC
$71.7B
$7.48M 0.35%
87,920
– –
2013 Q2
12 quarters
AIG icon
63
American International
AIG
$40.6B
$6.55M 0.31%
123,868
+4,356
+4% +$240K
2013 Q2
12 quarters
ALL icon
64
Allstate
ALL
$58.8B
$6.53M 0.31%
93,300
-1,880
-2% -$126K
2013 Q2
12 quarters
BNY icon
65
Bank of New York Mellon
BNY
$96.9B
$6.38M 0.3%
164,260
-2,018
-1% -$80.3K
2013 Q2
12 quarters
NWL icon
66
Newell Brands
NWL
$2.38B
$6.35M 0.3%
130,770
+124,920
+2,135% +$5.84M
2015 Q2
4 quarters
IBM icon
67
IBM
IBM
$214B
$6.19M 0.29%
42,640
+1,038
+2% +$149K
2013 Q2
12 quarters
AMP icon
68
Ameriprise Financial
AMP
$44.2B
$6.04M 0.28%
67,270
+1,875
+3% +$181K
2013 Q2
12 quarters
TMO icon
69
Thermo Fisher Scientific
TMO
$245B
$5.99M 0.28%
40,542
-895
-2% -$132K
2015 Q2
4 quarters
QCOM icon
70
Qualcomm
QCOM
$186B
$5.93M 0.28%
110,690
+7,858
+8% +$414K
2013 Q2
12 quarters
MO icon
71
Altria Group
MO
$120B
$5.28M 0.25%
76,578
+75
+0.1% +$4.8K
2013 Q2
12 quarters
MSFT icon
72
Microsoft
MSFT
$4.02T
$4.86M 0.23%
94,961
-2,900
-3% -$151K
2013 Q2
12 quarters
LMT icon
73
Lockheed Martin
LMT
$118B
$4.72M 0.22%
19,002
-109
-0.6% -$25.7K
2013 Q2
12 quarters
M icon
74
Macy's
M
$6B
$4.71M 0.22%
+140,214
New +$5.02M
2016 Q2
0 quarters
BMY icon
75
Bristol-Myers Squibb
BMY
$118B
$4.13M 0.19%
56,158
– –
2013 Q2
12 quarters
1 2
3
4 5

Similar funds

IA
IFG Advisory Atlanta, Georgia $2.85B AUM 26.07% 1-Year Est. Return
SEGHC
Saudi Electronic Games Holding Co Riyadh $2.85B AUM
CPCPP
Canada Post Corporation Pension Plan Toronto, Canada $2.87B AUM 37.96% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return
WGI
Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.88B AUM 23.24% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.84B AUM

Klingenstein Fields & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Klingenstein Fields & Co held 223 positions worth $2.14B, up 7% from $2B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Klingenstein Fields & Co deployed $83.4M of net new capital in Q2 2016, opening 11 new positions and adding to 84 existing holdings. Its largest new stake was Broadcom: 845,850 shares worth $13.1M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $20M trimmed.

  • Klingenstein Fields & Co's largest Q2 2016 buy was Broadcom: 845,850 shares worth $13.1M.
  • Klingenstein Fields & Co added most to CVS Health in Q2 2016, an estimated $21.5M increase.
  • Klingenstein Fields & Co's biggest Q2 2016 reduction was AbbVie, cutting an estimated $20M.
  • Klingenstein Fields & Co fully exited ABB Ltd in Q2 2016, selling an estimated $13.9M.
  • Klingenstein Fields & Co's ten largest holdings make up 41% of its $2.14B portfolio in Q2 2016.
  • Klingenstein Fields & Co opened 11 new positions and closed 12 in Q2 2016.
  • Klingenstein Fields & Co's portfolio value rose 7% quarter-over-quarter to $2.14B.

Based on Klingenstein Fields & Co's 13F filing for Q2 2016, filed 1 Aug 2016.